Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering Jan 14, 2025 04:00PM
Kazia Therapeutics (KZIA) Announces $2.0 Million Registered Direct Offering Jan 10, 2025 10:01AM
Kazia Therapeutics Announces $2.0 Million Registered Direct Offering Jan 10, 2025 09:58AM
Kazia Therapeutics (KZIA) Granted Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib Nov 4, 2024 07:31AM
Kazia Therapeutics Announces Granting of Type C Meeting with FDA to Discuss Potential Next Steps for Paxalisib in the Treatment of Newly Diagnosed Glioblastoma Multiforme Nov 4, 2024 07:30AM


May 17, 2022 08:00AM KAZIA MARKS DIPG AWARENESS DAY; NEW PRECLINICAL DATA IN DIPG TO BE PRESENTED AT ISPNO CONFERENCE
Mar 21, 2022 08:00AM KAZIA TO PRESENT AT UPCOMING INVESTOR CONFERENCE AND AACR ANNUAL SCIENTIFIC MEETING
Oct 14, 2021 08:04AM UPDATE: Maxim Group Starts Kazia Therapeutics (KZIA) at Buy